Derya Kabacaoglu

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options

H. Algül, D. Kabacaoglu, D. Ruess, 2018, Front. Immunol..

NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB

H. Algül, D. Kabacaoglu, D. Ruess, 2019, Cancers.

Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase

W. Birchmeier, D. Saur, R. Schmid, 2018, Nature Medicine.

The neuropeptide receptor subunit RAMP1 constrains the innate immune response during acute pancreatitis in mice.

R. Schmid, B. Holzmann, N. Hüser, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Targeting the Immune System in Pancreatic Cancer

H. Algül, D. Ruess, Derya Kabacaoglu, 2020 .

Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer

R. Bernards, B. Thijssen, S. Mainardi, 2022, Cell reports. Medicine.

Combined SHP2 and ERK inhibition for the treatment of KRAS-driven Pancreatic Ductal Adenocarcinoma

R. Bernards, B. Thijssen, N. Wu, 2021, bioRxiv.

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma

A. Carrato, C. Heeschen, F. Portillo, 2022, Gut.

Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.

C. Mantzoros, A. Walch, M. Aichler, 2019, Gastroenterology.

BCL3 couples cancer stem cell enrichment with pancreatic cancer molecular subtypes.

R. Braren, J. Slotta-Huspenina, R. Schmid, 2021, Gastroenterology.

A pancreas specific Ptf1a-driven Cre mouse line causes paternally transmitted germline recombination

M. Lesina, H. Algül, D. Kabacaoglu, 2020, bioRxiv.